Treatment of patients (pts) with chronic myeloid leukemia (CML) and imatinib failure after developing Bcr-Abl kinase mutations with allogeneic stem cell transplantation (ASCT)

被引：0
|
作者：
Jabbour, E [1 ]
Cortes, J [1 ]
De Lima, M [1 ]
Andersson, B [1 ]
Giralt, S [1 ]
Kantarjian, H [1 ]
Champlin, R [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
43
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [41] Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
    Jabbour, E.
    Kantarjian, H.
    Jones, D.
    Talpaz, M.
    Bekele, N.
    O'Brien, S.
    Zhou, X.
    Luthra, R.
    Garcia-Manero, G.
    Giles, F.
    Rios, M. B.
    Verstovsek, S.
    Cortes, J.
    LEUKEMIA, 2006, 20 (10) : 1767 - 1773
  • [42] Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
    E Jabbour
    H Kantarjian
    D Jones
    M Talpaz
    N Bekele
    S O'Brien
    X Zhou
    R Luthra
    G Garcia-Manero
    F Giles
    M B Rios
    S Verstovsek
    J Cortes
    Leukemia, 2006, 20 : 1767 - 1773
  • [43] BCR-ABL kinase domain mutations & SNPs in imatinib resistant or intolerant chronic myeloid leukaemia patients
    O'Connor, Lisa M.
    Langabeer, Stephen
    McCann, Shaun R.
    Conneally, Eibhlin
    BLOOD, 2007, 110 (11) : 699A - 700A
  • [44] BCR-ABL independent gene mutations in patients with chronic myeloid leukemia
    Schmidt, M.
    Rinke, J.
    Schaefer, V.
    Ziermann, J.
    Eigendorff, E.
    Hochhaus, A.
    Ernst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 210 - 210
  • [45] MUTATIONS OF THE BCR-ABL- KINASE DOMAIN EXPLAIN THE IMATINIB FAILURE ONLY IN A MINORITY OF PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Jardan, D.
    Talmaci, R.
    Coriu, D.
    Dragomir, M.
    Ursuleac, I.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 540 - 540
  • [46] THE ROLE OF STEM CELL TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) RESISTANT TO TYROSINE KINASE INHIBITORS WITH BCR-ABL KINASE DOMAIN MUTATION T315I
    Morozova, E.
    Vlasova, J.
    Afanasyev, B.
    HAEMATOLOGICA, 2015, 100 : 603 - 603
  • [47] The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology
    Witte, O
    SEMINARS IN HEMATOLOGY, 2001, 38 (03) : 3 - 8
  • [48] Spectrum of BCR-ABL Kinase Domain Mutations in North Macedonia in Patients With CML Resistant to Imatinib
    Stojanovska-Jakimovska, Simona
    Cvetanoski, Milche
    Ridova, Nevenka
    Trajkova, Sanja
    Popova-Labachevska, Marija
    Mojsovska, Tara
    Dukovski, Dushko
    Pivkova-Veljanovska, Aleksandra
    Stojanovski, Zlate
    Krstevska-Balkanov, Svetlana
    Pavkovic, Marica
    Chadievski, Lazar
    Panovska-Stavridis, Irina
    Ivanovski, Martin
    Gjorgievska, Emilija
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S375 - S375
  • [49] Efficacy of dasatinib in chronic phase chronic myelogenous leukemia patients after imatinib failure according to baseline BCR-ABL mutations
    Hochhaus, A.
    Branford, S.
    Radich, J.
    Mueller, M. C.
    Shah, N.
    Erben, P.
    Ernst, T.
    Acevedo, M.
    Nicaise, C.
    Hughes, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Efficacy of dasatinib in chronic phase chronic myelogenous leukemia patients after imatinib failure according to baseline BCR-ABL mutations
    Mueller, M. C.
    Branford, S.
    Radich, J.
    Shah, N.
    Erben, P.
    Ernst, T.
    Acevedo, M.
    Nicaise, C.
    Hughes, T.
    Hochhaus, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 127 - 127
12345